chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extreme pain in right arm with swelling of the wrist (Ganglion cyst) and ulnar nerve pain. Couldn't use right arm ,  extreme pain in any position, with or without motion. Gradually started getting better after 1 or 2 weeks. After 4 weeks arm is 90% back to normal
PATIENT WAS HERE FOR FLU SHOT AND PATIENT RECEIVED THE PFIZER VACCINE.  PT IS NOT HAVING ANY ISSUES AT THIS TIME.
20 y/o national guard male, presented to ER with weakness and fatigue, on exam was tachycardic, febrile and had chills.  EKG showed sinus tachycardia, EKG with sinus tachycardia with RBBB, Echo normal.  Troponin mildly elevated at 0.11, admitted for serial troponins and telemetry, released later in the morning.
Proquad was stored in the refrigerator instead of freezer; No further AE; This spontaneous report as received from a other health professional refers to a patient of unknown age and gender.      The patient's concurrent conditions, medical history and concomitant medications were not provided.  On 28-JAN-2021, the patient was vaccinated with an incorrect storage vaccine of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # T025221 with expiration date of 19-JAN-2022), 0.5 ml, for prophylaxis (route of administration was not provided); and with varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml, for prophylaxis (route of administration, lot# and expiration date were not provided). The vaccine measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was stored in the refrigerator instead of the freezer since 01-DEC-2020 with a temperature of 44F during 1506 hours and had since then been administered to patients. There was not previous temperature excursion and this was not call because of a data logger. There was not adverse event involved.
pt recv vax 29OCT98 by 5Pm T103;hives started then w/temp & c/o hives;swelling feet & hands;fever, cold, sore throat;pharyngitis (viral);6NOV98 pt still congested;mom mentioned allergy-did not feel from hep b;
This spontaneous report was received from a medical assistant regarding unspecified patients of unknown age and gender. Their medical history, concurrent conditions and concomitant medications were unknown. On an unknown date, an unspecified number of patients received improperly stored doses of VARIVAX (lot # M006731-valid [expiration date 09-FEB-2018], lot # M012990-valid [expiration date 14-MAR-2018], and lot # M049125 [expiration date 15-DEC-2018]) (dose and route unknown) for prophylaxis (incorrect product storage). No adverse effects were reported. Temperature was reported as 15 degrees Fahrenheit (F) to 46 degrees F (15.3 degrees F) for a time frame of 40 minutes. Previous temperature excursion was 15 degrees F to 46 degrees F (15 degrees F) for 3 hours and this was reported as a data logger. This is one of the multiple reports from the same reporter (US-009507513-1707USA006549 and US-009507513-1707USA008650). Additional information has been requested.; Sender's Comments:  US-009507513-1707USA008650: US-009507513-1707USA006549:
1 days p/vax pt devel cellulitis # inj site;cellulitis extended to the elbow;pt was hosp on 29AUG & tx w/IV ATB;cellulitis resolved on 30AUG;this is 1 of 2 pt from this site to have an adverse exp p/vax;
Patient received first vaccination dose of COVID-19 vaccine (Pfizer) on 5/22/2021. Patient was mistakenly given second dose early on 6/5/2021 (only 14 days after 1st vaccination). Per ACIP recommendations, second dose should be given no fewer than 17 days after 1st vaccine (max 4-day grace period). Per patient, has experienced no adverse reactions from receiving vaccine early. Per CDC guidance, repeat vaccination not necessary.
Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with a dose of PNEUMOVAX 23 (lot number 667590/1158Z). The physician reported that on "this week" (on approximately 14-SEP-2010) the patient experienced erythema from shoulder to elbow and tenderness. The physician also reported that the patient experienced redness, soreness and swelling. The physician gave the patient steroids and antihistamines. Therapy with PNEUMOVAX 23 discontinued. At the time of the report the patient had recovered. This is one of several reports received from the same source. Follow-up information was received from an other health care professional who stated that the female patient with allergies to albuterol, AVAPRO, ALUPENT, and Ciprofloxacine and no illness at time of vaccination, on an unspecified date was vaccinated with the first dose of PNEUMOVAX 23 (lot# 667690/1158Z). It was reported that the patient experienced soreness and swelling. The patient was treated with steroids and anti-histamines which calmed down the adverse events. There was not relevant diagnostic test. The patient did not seek medical attention. Follow-up information was received from another health professional who stated that the two lot numbers 666639/0564Z and 667690/1158Z were both male patients. Additional information has been requested.
12/29/04 Flu-Mist administer. On 12/31/04, patient had body aches and temperature of 101 degrees. On 01/03/05, patient  had cough, congestion, sore throat and fatigue. On 01/04/05, patients temperature was 101 degrees and on 01/06/05 it was down to 98.7 degrees.
Increased Heart rate/palpitations; Difficulty in breathing; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Increased Heart rate/palpitations), DYSPNOEA (Difficulty in breathing) and PYREXIA (Fever) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Polycystic ovarian syndrome and Hashimoto's thyroiditis. Concomitant products included METOPROLOL for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PALPITATIONS (Increased Heart rate/palpitations), DYSPNOEA (Difficulty in breathing) and PYREXIA (Fever). At the time of the report, PALPITATIONS (Increased Heart rate/palpitations), DYSPNOEA (Difficulty in breathing) and PYREXIA (Fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Electrocardiogram: normal (normal) normal. In March 2021, Troponin: negative (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was having iron pills (325 mg) and birth control as concomitant medication. No treatment medication were reported Patient has also undergone D-dimer test which was negative.   This case was linked to MOD-2021-219670 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Apr-2021: Follow up received and email address updated On 18-May-2021: Follow up received and no significant information updated On 11-Jun-2021: Follow up received contains concomitant drugs, medical history, laboratory data, and second dose details.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
it is a pinkish color from neck, inside of arms , to chest looks like bleachy rash but it's not rash; I saw discoloration on arm; painful arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (it is a pinkish color from neck, inside of arms , to chest looks like bleachy rash but it's not rash), SKIN DISCOLOURATION (I saw discoloration on arm) and VACCINATION SITE PAIN (painful arm) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN, ATENOLOL, AMLODIPINE and UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (ANORO ELLIPTA) for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced SKIN DISCOLOURATION (I saw discoloration on arm) and VACCINATION SITE PAIN (painful arm). On 12-Feb-2021, the patient experienced ERYTHEMA (it is a pinkish color from neck, inside of arms , to chest looks like bleachy rash but it's not rash). The patient was treated with PARACETAMOL (TYLENOL) for Pain relief, at a dose of 1 dosage form. At the time of the report, ERYTHEMA (it is a pinkish color from neck, inside of arms , to chest looks like bleachy rash but it's not rash), SKIN DISCOLOURATION (I saw discoloration on arm) and VACCINATION SITE PAIN (painful arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
face is all swollen/ face is all swollen around the mouth, lips and up the left side of his face; This case was reported by a pharmacist via call center representative and described the occurrence of facial swelling in a 74-year-old male patient who received Herpes zoster (Shingrix) (batch number 5KF37, expiry date 14th April 2020) for prophylaxis.   Concomitant products included benadryl (nos) (Benadryl).   On 4th May 2019, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 7th May 2019, 3 days after receiving Shingrix, the patient experienced facial swelling. On an unknown date, the outcome of the facial swelling was not recovered/not resolved.   It was unknown if the reporter considered the facial swelling to be related to Shingrix.  Additional details were provided as follows: The pharmacist on the line reported that she gave a patient their second dose of Shingrix on Saturday. On 07 May 2019, the patient had his face was all swollen around the mouth, lips and up the left side of his face, which was the side he had the immunization. The patient was fine that morning and he went to the golf course and came home and the left side of his face was swollen and he took Benadryl.
Within several hours, pt developed fever and abdominal cramps.  He was hospitialized for several days and recovered.  The reporter doubts the fever was related to the yellow fever vaccine.
mom states fever went up to 104 10PM 27MAR95;pt had immunization @ 10AM 27MAR95; mom states had been given APAP q 4 hr;mom states took pt to ER 10PM when fever went up to 104ax;t100.4; also cough & sneezing; mild elevation of white count
Allergy reaction; This spontaneous case was received on 21-Oct-2020 from other non-health professional (consumer) via Health Authority (reference number: SEQW20-04038) and concerned an elderly patient of unknown gender. At the time of this report, the patient was 77-year-old.  The patient's medical history and concomitant medications were not reported.   On unspecified date, the patient was vaccinated with Afluria Quadrivalent season 2018/2019 (influenza vaccine; dose: 0.5 ml, anatomical location and route of administration: not reported) for flu prevention. The batch number was not reported.   On unspecified date, after receiving Afluria Quadrivalent, the patient experienced allergy reaction.  The outcome of the event was not reported.  The reporter did not provide causality assessment.  The reporter assessed the case as non-serious.  Company comment: The event of 'allergy reaction' is assessed as related to Afluria Quadrivalent vaccine.; Sender's Comments: The event of 'allergic reaction' is assessed as related to Afluria Quadrivalent vaccine.
Metallic taste and smell on EVERYTHING since ive received second dose on 02/25/2021
Pt recv vax on 10/15/98; on same day pt exp redness, swelling &induration of left thigh, tender to touch; pt very irritable.
Small amount of vaccine leaked  between syringe and needle. less than 1/2 the dose. only a drop or two fell out.
a dose of VARIVAX was mistakenly given to a 1 month old patient; This spontaneous report was received from a physician regarding a 1 month old patient of unknown gender. Information regarding the patient's concurrent conditions, medical history, historical drugs and concomitant therapies was not provided.   On 18-SEP-2020, a dose of varicella virus vaccine live (oka/merck) (VARIVAX) was mistakenly given to the patient due to human error (strength, dose, route of administration, lot number and expiration date were not reported).
left arm from deltoid down the arm painful with extensive swelling/erythema and possible cellulitis so prescribed cephalexin. fever, headache, nausea and vomiting.
slight pain in their arm; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for her mother who is 90-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 18Mar2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date, the caller, said that she, her mother, and her husband got the first dose last Thursday. The caller would like to know the timeframe of getting the second dose. The caller said she wishes to get her second dose later (22 days or 25 days) so that she can take care of her 90-year-old mother in case she gets any side effects. The caller mentioned that they have experienced slight pain in their arm after the first dose. Outcome of the event was unknown.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021344253 same drug/AE, different patient;US-PFIZER INC-2021344241 same drug/AE, different patient
New soreness, warm to touch, red and blotchy rash approximately 6 days after vaccine at the site of the injection.  Topical hydrocortisone and oral diphenhydramine.
This spontaneous report as received from a physician regarding a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 08-JUL-2015, the patient received improperly stored VARIVAX (Merck) (lot#J012151, expiry date: 28-SEP-2015, dosing details were not specified) which was stored at 23 Fahrenheit for 27:00 hours. There was not concomitant medication reported. No adverse effects was reported and no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Body aches; This is a spontaneous report from a contactable consumer (patient). A 88-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Batch/Lot Number: not reported) via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history included hyperthyroidism. The patient's concomitant medication included methimazole. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Batch/Lot Number: not reported) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation and she and her mother had similar reaction like arm soreness and low fever then it went away. On an unspecified date, the patient experienced body aches. Caller stated body aches comes and goes and they are not getting any less. Caller wanted to know if its normal. The outcome was recovered.  The lot number for the vaccine was not provided and will be requested during follow up.
Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Hyperventilation-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Shakiness-Mild, Systemic: Weakness-Medium, Additional Details: After 15 minutes from injection she slumped to the floor, lips were quivering, c/o weakness and numbness in arms, hyperventilating, BP 130/82, pulse regular at 82.  Called 911.
Swelling of face; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Swelling of face) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SWELLING FACE (Swelling of face). At the time of the report, SWELLING FACE (Swelling of face) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Pt vaccinated with measles vaccine developed red rash, itchy 7 days after receiving vaccine, low grade temp 99.4 po, nausea, occ dizziness, swollen glands, hard to swallow.
Developed multiple dvt and pe one week after vaccine. Patient started on heparin drip the bridged to coumidin then switched to xarelto.
Trigeminal neuralgia has been totally under control using prescribed  medications.  Shortly after the first vaccination started having occasional episodes despite taking medications as prescribed.  After second shot, INTENSE episodes that medication does not control.  Losing work, cannot talk at times, excruciating electrical, jabbing pains in face.    Definitely neurological issues exacerbated by the vaccine.
Severe nosebleed lasting over an hour despite pinching nostrils, leaning forward, and applying ice to bridge of nose.  I rarely experience even minor nosebleeds, less than once per year.  I have never had a severe persistent nosebleed.
Info has been received from a licensed practical nurse concerning a pt who was vaccinated with a 1st dose of pneumococcal vaccine 23 polyvalent. Subsequently the pt developed cellulitis. The pt sought medical attention and was reportedly treated with antibiotics. It was that the pt was not hospitalized. It was also reported that some other patients and employees developed injection site soreness and redness (WAES #0211USA01238) after vaccination with pneumococcal vaccine 23 polyvalent. Additional info has been requested.
At 10:50am, the patient stated that she was started to have a weird taste in  her mouth and then she stated she started to feel light headed. By 10:55am she was given 25mg of liquid Benadryl and we had placed a cold cloth on the back of her neck. We had the patient stay a little longer to ensure it started to kick in and she asked us for a lemon drop. We don't have those in the store, so I grabbed her peppermint. When I got back from getting that, the light headedness went away and was starting to feel better and normal taste was returning. We also grabbed the patient a water. By 11:05am she was feeling much better and she went home. She was going to call me if anything else came up after she left. I will follow up with her tomorrow.
Patient reports to the ED w/ 7 days of headache, vomiting, and "seizures."  It's difficult for ED staff to determine if these were truly tonic-clonic seizures, generalized, or other.   Patient reports being awake for these seizures and that she remembers them.  Unsure if patient is describing "chills/shivering" as seizures, but the terminology used by patient/staff/MD/translators is seizures.  Patient has no recent history of seizures, and only history (ever) was 21 years ago when she was pregnant w/ 3rd child -- she had 1 seizure, accompanied by nausea/vomiting.
Severe headache & neck ache  even after taking Tylenol - reduced to mild at time of survey Mild all over body aches - on going at time of survey Pain when bending joints - resolved at time of survey Moderate radiating pain from shoulder to elbow of the injection arm - on going at time of survey
A report was received from a healthcare professional on Dec 2 2005 concerning a 26 year old female vaccinee. The vaccinee was 16 1/2 weeks pregnant at time of vaccination. On Nov 23 2005 the vaccinee received Fluvirin intramuscularly. 4 days later, on Nov 27 2005 the vaccinee experienced a severe headache and neck stiffness. The vaccinee was directed to the ER on Dec 1 2005 where she was diagnosed with viral meningitis. The out come was not reported.
1 min post vaccination(5:43pm) pt complained of dizziness/lightheadedness. Water provided. Pallor noticed, pt appeared diaphoretic. LOC for approximately 7 seconds with slight jerking of limbs noted. Pt regained consciousness while still seated. Pt placed in lying position on a cot. VS initiated, WNL for pt. Ice packs applied to nape of neck and extremities. VS taken q4. Pt reported feeling better while on cot, denies any symptoms. Pt transferred to seated position at 1758, tolerated well. Pt went from standing to sitting at 1804, tolerated well.
Vaccine expired on 13-Oct-2021 and then stored in refrigerator on 26-Oct-2021; Doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 13-Oct-2021 and then stored in refrigerator on 26-Oct-2021) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 13-Oct-2021 and then stored in refrigerator on 26-Oct-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 13-Oct-2021 and then stored in refrigerator on 26-Oct-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  Reporter stated that vaccine did not undergo any temperature excursion and patient did not experienced any adverse event and the date vaccine placed in refrigerator was on 26-Oct-2021.
Red, raised, feverish area around injection site approximately 8cm in diameter. Non tender.
My periods got way worse after the first dose. Now I have cramps that two full days. Causing problems with work and school.
2 days after vaccination, noticed bright red area at site of injection. 1 1/2" x 1 1/2" square area. Also slight rash above site - no lesions - no itch. Color faded over 1 week time period.
experienced pain after the first dose; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of PAIN (experienced pain after the first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN (experienced pain after the first dose). At the time of the report, PAIN (experienced pain after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication provided no treatment information provided   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: TCR attached. reporter's details updated on 29-apr-2021. no adverse events are reported.
pt returned to clinic 7 days later w/c/o itching & redness @ inj site;area 7.5 x 8.5cm macular inflammation, sl edema;no induration;